https://www.reuters.com/article/health-coronavirus-oxford-idUSKBN26L1NX

8 0

LONDON (Reuters) - Oxford University said on Wednesday it would study whether the world’s best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies. FILE PHOTO: People walk past an illustration of a virus outside a regional science centre, as the city and surrounding areas face local restrictions in an effort to avoid a local lockdown being forced upon the region, amid the coronavirus disease (COVID-19) outbreak, in Oldham, Britain August 3, 2020. REUTERS/Phil Noble/File Photo. Adalimumab, which is sold under the brand name Humira by AbbVie, is a type of anti-inflammato... Full story

30 September

wait